MONCTON, New Brunswick and CAMBRIDGE, Mass., February 25, 2025 – Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced the launch of its first large multi-center observational collection…
Moncton, New Brunswick–(February 19, 2025) – Breathe Biomedical Inc (Private) (“Breathe” or the “Company“), a company developing a breath analytics platform for early disease detection, is pleased to announce it will be presenting at…
MONCTON, NB, January 9th, 2024 – Breathe BioMedical (BBM) is pleased to announce the appointment of Dr. Rachel Brem to the company’s Board of Directors in her newly appointed role of Executive Director and Chief Medical Officer.…
MONCTON, NB, September 5th, 2023 – Breathe BioMedical (BBM) has announced Bill Dawes as their new Chief Executive Officer (CEO), effective August 14, 2023. Bill has served as the Chief Business Officer (CBO) at BBM over the last two…
MONCTON, NB, May 26th, 2023 – Breath biomarkers demonstrate high accuracy in detecting early-stage breast cancer in women with dense breast tissue. Innovative research using Breathe BioMedical’s breath analytics technology has shown promising results…
A Canadian company invented a non-invasive breath test that will detect breast cancer, neurodegenerative diseases and respiratory illnesses.
Blow into a machine to detect cancer. This is the principle of a new tool, developed locally by the medical technology company Breathe BioMedical, which is similar to the breathalyzer. If its effectiveness is…
Seeking an accessible diagnostic medium, researchers are rooting through the concoction of compounds in exhaled breath vapor for the metabolic manifestations of disease.
Technologies in development could make cancer screening less of a hassle and more widely available. After his godmother and his business partner’s mother both died of breast cancer, Rubens Fernando Mendrone made a radical…
